Key Items To Consider: (3-min read)
COVID Around The World
The coronavirus, otherwise known as COVID-19, has thrown the world into a shock. The virus – infecting over 99 million and killing over 2 million over the planet – has altered daily lifestyle and created a global pandemic. As of now, the US leads with over 25 million cases and just below 420 thousand deaths, followed by India and Brazil. But the news isn’t all bleak. Data has shown that over 71 million people have recovered from the virus, and the vaccine development process has shown success in trials, such as those seen in the US: Moderna and Pfizer. As of now, many countries, including China, the UK, Israel, and many more have started to administer the vaccine
America’s Vaccination Path
With the election coming to a close, the country will undergo a change in the vaccination plan. During President Trump’s time in office, Operation Warp Speed was in place, which focused on development, manufacturing, and distribution.
Operation Warp Speed Leaders:
Funded through the government, including the CARES act, the operation is given around $10 billion meant for the goal of researching and developing a vaccine as soon as possible, with around $3 billion for NIH (National Institute of Health) research and around $6.5 billion for development through BARDA (Biomedical Advanced Research and Development Authority).
Biden expresses his plan to vaccinate the country amid the pandemic by revealing a $1.9 trillion stimulus plan, with a focus on vaccination and relief (around $400 billion). He aims to achieve 100 million doses within his first 100 days in office. His plan works to identify priority groups for the vaccines, acquire enough staff to administer the vaccine, fix the supplying and distribution process of the vaccine, and lastly, have a campaign to educate Americans about the vaccine. At present, over 12 million doses have been administered, with two major vaccines entering into America: Pfizer-BioNTech and Moderna, each being a two-shot vaccine.
Vaccines Around The World
When it comes to vaccines, a composition of data done on December 11th, 2020, was completed. The following diagram illustrates the vaccine companies who have begun distribution, and to whom they have distributed to (keep in mind that the numbers are different as of mid-January).
The bad news coming from the large production of vaccines comes from a vaccine developed by Beijing-based Sinovac. With over 90% efficacies seen in vaccines like those made by Moderna and Pfizer, this vaccine shows low and mixed results. Trials begin, showing efficiency rates of over 97%, and within three to four months, the rate has now dropped to 50.4%. Such drops have lowered confidence in vaccination, but are still valuable in places such as Turkey, where results show prevention of severe cases. Vaccines from Sinovac are being distributed and have been approved even with such results.
- COVID-19 has changed the lives of many, infecting over 99 million people and killing over 2 million people globally
- Even with a large number of cases, America leads in the vaccination process, having administered over 20.5 million doses of the vaccine, with over 3 million people fully vaccinated
- The transition of power has led to change in the vaccination process between President Trump’s team and President Biden’s team
- America has seen the implementation of both Moderna and Pfizer in its vaccination process
- Sinovac, a Beijing-based vaccine, has shown mixed results in terms of the efficacy of the virus, having been tested in places such as Brazil and Turkey